Top Stories

UK decision to delay second Covid vaccine shot endorsed by advisors


A pharmacist dilutes the Pfizer COVID-19 vaccine while preparing it to administer to staff and residents at the Goodwin House Bailey’s Crossroads, a senior living community in Falls Church, Virginia, on December 30, 2020.

Brendan Smialowski | AFP | Getty Images

LONDON — Health experts have conditionally backed the U.K.’s decision to delay administering a second dose of the coronavirus vaccine developed by Pfizer and BioNTech, warning that the need to suppress the new coronavirus strain “cannot be overstated.”

It comes shortly after the U.K. said second doses of the Pfizer-BioNTech jab, in addition to the newly-approved Covid-19 vaccine developed by AstraZeneca and the University of…


Stock futures up after S&P 500 suffers first negative start to a year since 2016

Previous article

European markets slide as new lockdown measures set to take effect in the U.K. and Germany

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories